Compare Hims and Hers Health Inc (HIMS) vs Kimberly Clark Corp (KMB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs Kimberly Clark Corp — how do they compare? Hims and Hers Health Inc trades at $32.7 (market cap $7.57B), while Kimberly Clark Corp trades at $109.33 (market cap $36.01B). The key difference: Kimberly Clark Corp is far larger — about 4.8× Hims and Hers Health Inc's market cap, and Kimberly Clark Corp pays a 4.72% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals.
| HIMS | KMB | |
|---|---|---|
Market Cap | $7.57B | $36.01B |
Sector | Health | Consumer Staples |
52-Week High | $66.18 | $136.77 |
52-Week Low | $14.52 | $93.05 |
Enterprise Value | $7.95B | $42.55B |
Dividend Yield | — | 4.72% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hims & Hers Health trades at $32.70, down 0.43% on the day, with a mixed technical picture showing bullish moving averages but neutral oscillators. Fundamentally, the company reported 2025 revenue of $2.35 billion and net income of $128.37 million, though 2026 projections indicate a net loss. Recent news highlights executive departures and anticipation for Q2 2026 earnings on August 10, 2026.
The investment outlook is cautiously optimistic, supported by a 35% analyst buy rating and a $33.57 consensus price target. Key opportunities include growth in the weight-loss drug segment and international expansion. Risks involve profitability volatility, intense competition, and reliance on telehealth regulatory frameworks. The stock's valuation remains elevated with a P/E of 57.14, demanding strong future earnings growth to justify current levels.
Kimberly-Clark (KMB) trades at $108.05, down 0.28% on the day, with a neutral technical signal. The stock shows strong profitability with a net income margin of 12.8% and has beaten earnings estimates for the last three quarters. Recent news highlights its status as a Dividend King and strategic moves like the Arbex joint venture. Cash flow trends indicate operational strength despite recent net outflows.
KMB offers a stable investment with a solid dividend yield and consistent earnings beats, but faces risks from high payout ratios and competitive pressures. Analyst consensus is mixed with a hold-heavy rating, though the $115.33 price target suggests modest upside. Revenue declines in 2025 warrant monitoring for sustained growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About Kimberly Clark Corp
With around half of sales from personal care and another third from tissue products, Kimberly-Clark sits as a leading manufacturer of tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary products for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Read more on KMB →
